Shows
CMEBiomarkers of the Storm: Decoding IRI’s Signature
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCMEThe Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCME/CEWhat’s on the Horizon for IRI Management?
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCME/CEBiomarkers of the Storm: Decoding IRI’s Signature
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCME/CEThe Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCMEBiomarkers of the Storm: Decoding IRI’s Signature
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCMEWhat’s on the Horizon for IRI Management?
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCMEWhat’s on the Horizon for IRI Management?
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCMEThe Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCME/CEBiomarkers of the Storm: Decoding IRI’s Signature
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCME/CEThe Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 minCME/CEWhat’s on the Horizon for IRI Management?
Guest: Manesh R. Patel, MD
Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart failure and increased cardiovascular mortality. By providing a comprehensive overview of IRI, this program aims to enhance understanding and inform...2024-10-0200 min
From Lab to LifeWorsening Heart Failure | Episode ThreeFor CME Information and to Claim Your Credit: www.iridiumce.com/hfHost:Dr. Bob UnderwoodGuest:Dr. Deepak BhattDirector of Mount Sinai HeartDr. Valentin Fuster Professor of Cardiovascular Medicine at Icahn School of MedicineSupported by:Independent educational grant from Merck, Sharp, and DohmeEpisode Overview:In this episode, Dr. Bob Underwood and Dr. Deepak Bhatt discuss novel heart failure medications for both heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF). They explore the latest advancements in treatment, including the four pillars...2024-10-0123 min
Business TalkProf. Stephan Meier on “The Employee Advantage: How Putting Workers First Helps Business Thrive”In the latest episode of Business Talk, we had the pleasure of hosting Prof. Stephan Meier, Chair of the Management Division and the James P. Gorman Professor of Business at Columbia Business School. Prof. Meier offers an in-depth look into his forthcoming book, "The Employee Advantage: How Putting Workers First Helps Business Thrive."
In this enlightening discussion, Prof. Meier explores the transformative impact of prioritizing employees and how this approach can significantly enhance business success. Don't miss this opportunity to gain valuable insights from one of the leading voices in management and business strategy.
Tune in to discover how putting...2024-08-0442 min
Business TalkProf. Rohit Prasad Discusses His Book "The Last Dance of Rationality – Making Sense of an Unraveling World Order” | Business TalkWelcome to the latest episode of Business Talk. Today, we have the privilege of hosting Prof. Rohit Prasad, a distinguished professor in the areas of Economics and Public Policy at the Management Development Institute (MDI) Gurgaon. Prof. Rohit Prasad is also the Area Chairperson for the Economics & Public Policy area at MDI Gurgaon. Join us as we delve into the complexities and insights of our changing world through the lens of Prof. Prasad's remarkable work.
About Prof. Rohit Prasad:
Rohit Prasad is an eminent Professor of Economics and Public Policy at MDI Gurgaon, holding a Ph.D. in Economic Theory...2024-07-1621 min
ESC TV Today – Your Cardiovascular NewsOmega-3 fatty acids - Lead induced tricuspid regurgitationESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent studies All you need to know about omega-3 fatty acids Lead induced tricuspid regurgitation MythBusters: Pomegranates are heart-healthy Host: Rick Grobbee Guests: Carlos Aguiar, Martin Andreas, Deepak Bhatt Want to watch that episode? Go to: https://esc365.escardio.org/event/1150 Disclaimer This programme is intended for health care professionals only and...2024-05-0921 min
Health Professional Radio - PodcastFinal Dataset of Phase 2 ENTRIGUE Trial of PegozaferminDr. Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s pegozafermin in patients with severe hypertriglyceridemia (SHTG) that was published online in "Nature Medicine" (June 24, 2023). To learn more about pegozafermin’s indications in non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG), please visit https://www.89bio.com/pipeline/.
#SHTG #89bio #NatureMedicine
Deepak L. Bhatt MD, MPH, FACC, FAHA, MSCAI, FESC, is Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medi...2023-10-1710 min![Alap [Tilos Rádió podcast]](https://tilos.hu/upload/episode-new/alap.jpg)
Alap [Tilos Rádió podcast]Vishwa Mohan Bhatt, Tarun Bhattacharya, Shujaat KhanVishwa Mohan Bhatt - Mohan VeenaTarun Bhattacharya - SanturRaga Ahir Bhairav
Shujaat Khan - SitarRaga Deepak2023-09-171h 58
The Shape of Work#265: Deepak Agarwal on making R&R efficient, significant upcoming business trends, and overcoming WFH challenges.On this episode of The Shape of Work, our guest shares how organizations should instill Rewards and Recognition policies without losing its charm.“Rewards and recognition policy should be created in this way: appreciation should have a deeper meaning & not on the surface level. It shouldn't happen too frequently. Otherwise, it's not going to serve its purpose.”We welcome Deepak Agarwal, Founder & CEO at Auric- a Beauty & Wellness food brand based on Ayurveda.Prior to establishing his venture, he worked at Unilever for 8-plus years. He held numerous roles, including Hair...2022-12-0513 minESC TV Today – Your Cardiovascular NewsEpisode 4: Highlights of the ESC cardio-oncology guidelines - New data in renal denervation: SYMPLICITY HTN-3ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly. This episode covers: Cardiology This Week: A concise summary of recent trials Highlights of the ESC Cardio Oncology Guidelines New Data in Renal Denervation: SYMPLICITY HTN-3 Mythbusters: Coffee increases the risk for heart disease Host: Rick Grobbee Guests: Carlos Aguiar, Teresa Lopez Fernandez and Deepak Bhatt Want to watch that episode? Go to: https://esc365.escardio.org/event/607 Disclaimer: This programme is intended for...2022-11-1022 min
Episodes Archives - Cardionerds240. CardioNerds Rounds: Challenging Cases – Antithrombotic Management with Dr. Deepak Bhatt
It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of Texas at Auston, Dell Medical School) joins Dr. Deepak Bhatt (Dr. Valentin Fuster Professor of Medicine and Director of Mount Sinai Heart) to discuss the nuances of antithrombotic therapy. As one of the most prolific cardiovascular researchers, clinicians, and educators, CardioNerds is honored to have Dr. Bhatt on Rounds, especially given that Dr. Bhatt has led numerous breakthroughs in antithrombotic therapy. Come round with us today by listening to the episodes of #CardsRounds! Audio editing by CardioNerds Academy Intern, Dr. Christian Faab...2022-11-0346 minCoronary Artery Disease Archives - Cardionerds240. CardioNerds Rounds: Challenging Cases – Antithrombotic Management with Dr. Deepak Bhatt
It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of Texas at Auston, Dell Medical School) joins Dr. Deepak Bhatt (Dr. Valentin Fuster Professor of Medicine and Director of Mount Sinai Heart) to discuss the nuances of antithrombotic therapy. As one of the most prolific cardiovascular researchers, clinicians, and educators, CardioNerds is honored to have Dr. Bhatt on Rounds, especially given that Dr. Bhatt has led numerous breakthroughs in antithrombotic therapy. Come round with us today by listening to the episodes of #CardsRounds! Audio editing by CardioNerds Academy Intern, Dr. Christian Faab...2022-11-0346 minRounds Archives - Cardionerds240. CardioNerds Rounds: Challenging Cases – Antithrombotic Management with Dr. Deepak Bhatt
It’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of Texas at Auston, Dell Medical School) joins Dr. Deepak Bhatt (Dr. Valentin Fuster Professor of Medicine and Director of Mount Sinai Heart) to discuss the nuances of antithrombotic therapy. As one of the most prolific cardiovascular researchers, clinicians, and educators, CardioNerds is honored to have Dr. Bhatt on Rounds, especially given that Dr. Bhatt has led numerous breakthroughs in antithrombotic therapy. Come round with us today by listening to the episodes of #CardsRounds! Audio editing by CardioNerds Academy Intern, Dr. Christian Faab...2022-11-0346 minCardionerds: A Cardiology Podcast240. CardioNerds Rounds: Challenging Cases – Antithrombotic Management with Dr. Deepak BhattIt’s another session of CardioNerds Rounds! In these rounds, Dr. Priya Kothapalli (Interventional FIT at University of Texas at Auston, Dell Medical School) joins Dr. Deepak Bhatt (Dr. Valentin Fuster Professor of Medicine and Director of Mount Sinai Heart) to discuss the nuances of antithrombotic therapy. As one of the most prolific cardiovascular researchers, clinicians, and educators, CardioNerds is honored to have Dr. Bhatt on Rounds, especially given that Dr. Bhatt has led numerous breakthroughs in antithrombotic therapy. Come round with us today by listening to the episodes of #CardsRounds! Audio editing by CardioNerds Academy Intern, Dr. Christian Faaborg-Andersen.
This...2022-11-0346 min
JagarTv PodcastNaveen Bhatt Garhwali and Kumaoni Song Writer on JagarTv PodcastSaun Maina, Tera Nakhra Dekhi, Almora Bazar, Khayalo Maa Tu, Dua Kaiki Lagi, Hiya Basigey, Hiya Ki Dor are some of the garhwali/kumaoni hit songs written by Naveen Bhatt also known as Nabbu. Naveen Bhatt is known for the phenomenal use of pahadi words with decency. Naveen Bhatt also writes poems and Shayari. Naveen Bhatt's work is praised and loved a lot in the state. Discover all about Naveen Bhatt(Nabbu), his hidden initiatives, future plans, life challenges, mindset, success stories, and many more in this Episode 8 of JagarTv Original Podcast.
👉 Naveen Bhatt's Instagram: htt...2021-07-141h 04
Parallax by Ankur KalraEP 50: Conversation with Dr Deepak L Bhatt: Physician, Researcher, & MentorEarly in his career, Dr. Deepak L. Bhatt was considering becoming a basic science researcher. After an exchange with one of his mentors about doing science for the science’s sake, he had a self-realisation: He wanted his work to have a direct impact on patient care.
In the 50th episode of Parallax, Dr. Ankur Kalra’s guest is Dr. Deepak L. Bhatt leading physician, researcher, lecturer, and educator who has authored or co-authored over 1650 publications and was recipient of the ACC’s Distinguished Mentor Award in 2018 and AHA’s Distinguished Scientist Award in 2019.
In this candid and personal interview, Dr. Bhat...2021-06-1946 min
MedEdTalks - CardiologyRecent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak BhattIn this podcast, expert clinicians will discuss latest clinical evidence from cardiovascular outcomes trials and how reducing triglycerides for further reduces risk.2021-03-2416 min
Lipid InsightsS2E1: Omega 3 Outcome Trials in Perspective Part 2Join Dr. Alan Brown as he sits down with Dr. Deepak Bhatt and Dr. Christie Ballantyne to discuss the outcomes of recent omega 3 trials and the controversies that surround them.2021-02-0820 minLipid InsightsS2E1: Omega 3 Outcome Trials in Perspective Part 1Join Dr. Alan Brown as he sits down with Dr. Deepak Bhatt and Dr. Christie Ballantyne to discuss the outcomes of recent omega 3 trials and the controversies that surround them.2021-02-0531 min
Don't Miss a BeatDeepak Bhatt, MD: Impact of COVID-19 on Cardiovascular TrialsFor this episode, you will be hearing from Dr. Deepak Bhatt. Dr. Bhatt is the lead author of a recent article published in the Journal of the American Heart Association examining the impact of the ongoing COVID-19 pandemic.
A leading trialist, Dr. Bhatt offers perspective on data and from personal experience on how the pandemic has, is, and will continue to effect clinical trials, with the ripple causing disruptions in treatment pipelines and the treatment of patients.
2020-07-3116 min
Unmasking COVID-19Immunocompromised PatientsAs the enormity of the COVID-19 pandemic sinks in and as we feel its impact across the globe, join us as we discuss mitigation, solutions and new discoveries and approaches to help you better prepare to serve your patients across all specialties. In this episode, we focus on immunocompromised patients. Questions: From David Duong, MD, from the Harvard Primary Care Center: Should the safe default be to recommend testing for COVID-19 if they have any URI +/- diarrheal symptoms since the implications could be huge for them? Or is there additional screening that...2020-04-0619 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 3 Highlights | ACC.20/WCC VirtualIn this special episode of Eagle's Eye View, Dr. Peter Block and Dr. Deepak Bhatt discuss highlights from Day 3 of ACC.20/WCC Virtual, including TICO, TWILIGHT Diabetes and TWILIGHT-COMPLEX Substudies, Radial Artery Versus Saphenous Vein for Coronary Bypass Surgery at Long-Term Follow-Up, PRECOMBAT, and REDUCE-IT EPA.2020-03-3014 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 2 Highlights | ACC.20/WCC VirtualIn this special episode of Eagle's Eye View, Dr. Peter Block and Dr. Deepak Bhatt discuss highlights from Day 2 of ACC.20/WCC Virtual, including SPYRAL HTN-OFF MED Pivotal, PRONOMOS, AUGUSTUS, and the Caravaggio Study.2020-03-2914 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 1 Highlights | ACC.20/WCC VirtualIn this special episode of Eagle’s Eye View, Dr. Peter Block and Dr. Deepak Bhatt discuss highlights from Day 1 of ACC.20/WCC Virtual, including VICTORIA, VOYAGER PAD, COMPASS Diabetes, and TAILOR PCI.2020-03-2915 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (ACC.20/WCC Virtual Preview)In this week's View, guest host Dr. Deepak Bhatt offers a preview of some of the hottest trials at ACC's Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) Virtual, taking place online only March 28-30, including VICTORIA, VOYAGER PAD, COMPASS, TAILOR PCI, SPYRAL HTN-OFF MED PIVOTAL, TWILIGHT, TICO, E3, REDUCE-IT, and ISCHEMIA.2020-03-2008 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (Week of February 17)In this week's View, guest host Dr. Deepak Bhatt gives us an update from the SOLVE-TAVI trial; talks about the diagnostic performance of FFRangio, an angiogram-derived fractional flow reserve technology; and introduces the HUNT study, which looked at physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation.2020-02-1905 min
HCPLive PodcastsCardiology in 2019 with Deepak Bhatt, MD, MPHA conversation with Deepak Bhatt, MD, MPH, discussing the most impactful advances in cardiology in 2019 and what he sees as the most important advances in the past decade as 2019 comes to a close.
——————————————————————————————————
Campfire by Scandinavianz | https://soundcloud.com/scandinavianz
Music promoted by https://www.free-stock-music.com
Creative Commons Attribution 3.0 Unported License
https://creativecommons.org/licenses/by/3.0/deed.en_US
2019-11-2012 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 3 Highlights | AHA 2019In this special episode of the View, Dr. Peter Block, Dr. Kim Eagle, and Dr. Deepak Bhatt discuss highlights from Day 3 of AHA.19, including Evaporate: Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin, the Treat Stroke To Target trial results, and Impella versus intra-aortic balloon pump in the United States.2019-11-1811 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 2 Highlights | AHA 2019In this special episode of the View, Dr. Peter Block, Dr. Kim Eagle, and Dr. Deepak Bhatt discuss highlights from Day 2 of AHA.19, including the effect of treatment according to age in the DAPA-HF trial, early surgery versus conventional management for asymptomatic severe aortic stenosis in the RECOVERY trial, and results from the 3,146 patients randomized in the United States in the REDUCE-IT USA trial.2019-11-1810 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 1 Highlights | AHA 2019In this special episode of the View, Dr. Peter Block and Dr. Deepak Bhatt discuss highlights from Day 1 of AHA.19, including the Dapagliflozin and Prevention of Adverse-Outcomes in HF Trial (DAPA-HF), the Colchicine Cardiovascular Outcomes Trial (COLCOT), and the International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches (ISCHEMIA) trials.2019-11-1712 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (AHA.19 Preview)In this week's View, guest host Dr. Deepak Bhatt offers a preview of some of the hottest trials at the American Heart Association Scientific Sessions 2019, taking place November 16-18 in Philadelphia, PA, including ISCHEMIA, ISCHEMIA QoL, ISCHEMIA-CKD, DAPA-HF, COLCOT, Treat Stroke To Target, REDUCE-IT Cost-Effectiveness, REDUCE-IT USA, EVAPORATE, PARADIGM-HF, and PARAGON-HF.2019-11-0805 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (TCT 2019 Preview)In this week's View, guest host Dr. Deepak Bhatt offers a preview of some of the hottest trials at TCT 2019, taking place September 25-29 in San Francisco, CA, including TWILIGHT, AUGUSTUS ACS, PORTICO, PARTNER 3 Low-Risk Computed Tomography Substudy, Three-Year Outcomes from COAPT, Five-Year Outcomes from PARTNER 2A, Five-Year Outcomes from EXCEL, COMPLETE Timing Substudy, Cost-Effectiveness Analysis from COAPT, Health Status Outcomes from PARTNER 3, and Five-Year Outcomes from IVUS-XPL.2019-09-1907 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 4 Highlights | ESC Congress 2019In this special episode of the View, Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss Day 4 of ESC Congress 2019, including genotype-guided oral P2Y12-inhibition in patients with ST-segment elevation myocardial infarction undergoing primary PCI (POPular Genetics); edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients (ENTRUST-AF PCI); and more.2019-09-0407 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 3 Highlights | ESC Congress 2019In this special episode of the View, Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss Day 3 of ESC Congress 2019, including rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease (AFIRE); effects of sacubitril-valsartan compared with enalapril on arterial hemodynamics and cardiac remodeling in patients with heart failure and reduced ejection fraction (EVALUATE-HF, PROVE-HF); and more.2019-09-0307 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 2 Highlights | ESC Congress 2019In this special episode of the View, Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss Day 2 of ESC Congress 2019, including ticagrelor compared to placebo added to low-dose aspirin in patients with stale coronary artery disease (THEMIS and THEMIS-PCI); angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction and dapagliflozin and prevention of adverse outcomes in heart failure (PARAGON-HF and DAPA HF); and more.2019-09-0211 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 1 Highlights | ESC Congress 2019In this special episode of the View, Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss Day 1 of ESC Congress 2019, including objective risk assessment versus standard care for acute coronary syndromes (AGRIS); the relationship between hypoglycemia, cardiovascular outcomes, and empagliflozin treatment (EMPA-REG OUTCOME); and maximum-fixed energy versus low-escalating energy shocks for cardioversion of atrial fibrillation (CHESS).2019-09-0106 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (ESC Congress 2019 Preview)In this week's View, guest host Dr. Deepak Bhatt offers a preview of some of the hottest trials at ESC Congress 2019, taking place August 31-September 4 in Paris, including ASCEND, THEMIS, THEMIS-PCI, PARAGON-HF, COMPLETE, HERMES, Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease, GALACTIC, ENTRUST-AF PCI, and POPular Genetics.2019-08-2308 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (Week of August 19)This week's View, guest hosted by Dr. Deepak Bhatt, investigates whether biomarkers can be used to identify subsets of patients post-acute coronary syndrome who would benefit best from adjunctive ezetimibe treatment, addresses the late results of mitral valve repair for mitral regurgitation due to mitral valve prolapse, and offers key points from the JACC Scientific Expert Panel opinion on the management of conduction disturbances associated with transcatheter aortic valve replacement.2019-08-2106 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (Week of August 5)This week's View, guest hosted by Dr. Deepak Bhatt, explores the incidence of sudden cardiac death among persons living with human immunodeficiency virus infection with heart failure, the effect of metformin on cardiovascular outcomes and all-cause mortality in patients with type 2 diabetes mellitus, the amputation-free survival and reintervention rates in patients treated with initial open surgical bypass or endovascular intervention for ischemic ulcers of the lower extremities, and more.2019-08-0806 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (Week of July 29)This week's View, guest hosted by Dr. Deepak Bhatt, explores the impact of prolonged spaceflight on orthostatic tolerance and blood pressure profile in astronauts, the prevalence of atrial fibrillation in former National Football League athletes compared with population-based controls, whether composite cardiovascular events are more prevalent in patients with rejected/abandoned proprotein convertase subtilisin kexin type 9 inhibitor prescriptions than in those whose prescriptions are paid, and more.2019-07-3106 min
Business Marketing FinanceWhy Good SEO Is Key For Your Business! - Deepak Shukla (SEO Consultant)Why Good SEO Is Key For Your Business! - Deepak Shukla (SEO Consultant)
My next guest came highly recommended, Deepak Shukla, SEO consultant, influencer, TEDx Speaker and founder of Pearl Lemon. Now if you’ve got a website, you know that you need to start generating traffic and ultimately start converting. Deepaks company helps companies reach the top of search engines and ultimately with their sales pipeline.
“It’s difficult to maintain stamina, because for the most part the world around you will be an accompanist in your lack of consistency”
MORE SPECIFICALLY, ON THIS E...2019-07-1037 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (Week of April 8, Part 2)Part 2 of this week’s View features guest host Dr. Deepak Bhatt, who covers the contemporary diagnosis-specific outcomes in pregnant women with heart disease, key points to remember from the American Heart Association Scientific Statement on the diagnosis and management of myocardial infarction in the absence of obstructive coronary artery disease, and the relative efficacies of sirolimus-eluting versus everolimus-eluting stents for target lesion revascularization.2019-04-1308 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Your Weekly CV Update From ACC.org (Week of April 8, Part 1)Part 1 of this week's View features guest host Dr. Deepak Bhatt, who explores the impact of chest compression-only cardiopulmonary resuscitation on survival among out-of-hospital cardiac arrest victims, the effect of endovascular thrombectomy cumulative case volume on outcomes of acute stroke patients, and the association between hospital or operator volume of transcatheter aortic valve replacement procedures and 30-day unadjusted and risk-adjusted outcomes.2019-04-1205 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 3 Highlights | ACC.19In this special episode of Eagle’s Eye View, Dr. Peter Block, Dr. Kim Eagle, and Dr. Deepak Bhatt discuss highlights from Day 3 of ACC.19, including IRAD: Acute Aortic Dissection: Lessons Learned From 9000 Patients, REDUCE-IT: Reduction in Total Ischemic Events With Icosapent Ethyl, DECLARE-TIMI 58 HFrEF: Dapagliflozin on HF and Mortality in T2D Based on EF, and SAFARI-STEMI: Femoral Access vs. Radial Access For Primary PCI in STEMI.2019-03-2011 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 2 Highlights | ACC.19In this special episode of Eagle’s Eye View, Dr. Peter Block, Dr. Kim Eagle, and Dr. Deepak Bhatt discuss highlights from Day 2 of ACC.19, including PARTNER 3: TAVR or SAVR in Low-Risk Patients, AUGUSTUS: Apixaban vs. Vitamin K Antagonist and Aspirin vs. Placebo in AFib and ACS, PCI, POET: Partial Oral Treatment of Left-Sided Infectious Endocarditis, and MOMENTUM 3: MagLev Technology in Mechanical Circulatory Support Therapy With HeartMate 3.2019-03-1808 min
Eagle's Eye View: Your Weekly CV Update From ACC.orgEagle's Eye View: Day 1 Highlights | ACC.19In this special episode of Eagle's Eye View, Dr. Peter Block and Dr. Deepak Bhatt discuss highlights from Day 1 of ACC.19, including the Apple Heart Study, PIONEER-HF: Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated HF, Hopeful Heart: Blended Collaborative Care For Treating HF and Comorbid Depression, and CODIACS-QoL: Depression Screening After ACS.2019-03-1706 min
Play to Potential Podcast36.00 OP Bhatt - Insights on excellence in BoardsGUEST
Mr Om Prakash Bhatt (OP Bhatt) is the Chairman of Tata Steel Limited and a Board Member at Oil and Natural Gas Corporation Limited (ONGC), Hindustan Unilever Limited (HUL) and Standard Chartered Bank. He started his career in State Bank of India (SBI) as a probationary officer in 1972 and retired as the Chairman of SBI in 2011. I had first met him when I was participating in the Director’s Club programme conducted by Hunt Partners, designed to prepare individuals to be effective Board Members.
In our conversation, we spoke about how leaders should think about wh...2018-10-2355 min
Heart MattersPPIs and Antiplatelet Therapy: Weighing the Benefits and Risks
Host: Janet Wright, MD
Guest: Deepak Bhatt, MD
One of the biggest risks of antiplatelet therapy is gastrointestinal bleeding. Because of this risk, patients on the antiplatelet clopidogrel are often prescribed proten pump inhibitors, or PPIs. However, there are also concerns about PPIs decreasing the efficacy of clopidogrel. What approach should physicians take for patients at moderate to high risk for upper GI bleeding? Host Dr. Janet Wright welcomes Dr. Deepak Bhatt, chief of cardiology at the VA Boston Healthcare System, director of the Integrated Interventional Cardiovascular Program at Brigham and Women's Hospital & VA Boston Healthcare System...2010-11-1000 minHeart MattersPPIs and Antiplatelet Therapy: Weighing the Benefits and Risks
Host: Janet Wright, MD
Guest: Deepak Bhatt, MD
One of the biggest risks of antiplatelet therapy is gastrointestinal bleeding. Because of this risk, patients on the antiplatelet clopidogrel are often prescribed proten pump inhibitors, or PPIs. However, there are also concerns about PPIs decreasing the efficacy of clopidogrel. What approach should physicians take for patients at moderate to high risk for upper GI bleeding? Host Dr. Janet Wright welcomes Dr. Deepak Bhatt, chief of cardiology at the VA Boston Healthcare System, director of the Integrated Interventional Cardiovascular Program at Brigham and Women's Hospital & VA Boston Healthcare System...2010-11-1000 min
Fellows’ corner on theheart.orgEpisode 9: From fellow to independent principal investigator: Insight from Dr Deepak BhattThe latest cardiology education and news - focused on training, research, and career planning. Through fellow conducted interviews of leading cardiologists, the Fellows’ corner provides a forum to share experience and knowledge while facilitating exchange and promoting optimal practice. Interviews are conducted by fellows from the leading US-based academic institutions and are produced on a monthly basis.
2009-04-1423 min
Listen to The LancetThe Lancet: June 20, 2008Drug-eluting stents revolutionised interventional cardiology owing to their pronounced ability to reduce restenosis compared with bare-metal stents. Attention has now shifted to safety of these devices because of evidence suggesting an association with late stent thrombosis. In a review, Anthony Bavry and Deepak Bhatt assess current evidence from randomised trials, and propose guidelines for the appropriate use of drug-eluting stents in clinical practice. Deepak Bhatt discusses the history of stents and assesses our current knowledge and considers treatment options for cardiologists and patients in this week's podcast.2008-06-2016 minListen to The LancetThe Lancet: June 20, 2008Drug-eluting stents revolutionised interventional cardiology owing to their pronounced ability to reduce restenosis compared with bare-metal stents. Attention has now shifted to safety of these devices because of evidence suggesting an association with late stent thrombosis. In a review, Anthony Bavry and Deepak Bhatt assess current evidence from randomised trials, and propose guidelines for the appropriate use of drug-eluting stents in clinical practice. Deepak Bhatt discusses the history of stents and assesses our current knowledge and considers treatment options for cardiologists and patients in this week's podcast.2008-06-2016 minListen to The LancetThe Lancet: June 20, 2008Drug-eluting stents revolutionised interventional cardiology owing to their pronounced ability to reduce restenosis compared with bare-metal stents. Attention has now shifted to safety of these devices because of evidence suggesting an association with late stent thrombosis. In a review, Anthony Bavry and Deepak Bhatt assess current evidence from randomised trials, and propose guidelines for the appropriate use of drug-eluting stents in clinical practice. Deepak Bhatt discusses the history of stents and assesses our current knowledge and considers treatment options for cardiologists and patients in this week's podcast.2008-06-2016 min
The Lancet in conversation withThe Lancet: June 20, 2008Drug-eluting stents revolutionised interventional cardiology owing to their pronounced ability to reduce restenosis compared with bare-metal stents. Attention has now shifted to safety of these devices because of evidence suggesting an association with late stent thrombosis. In a review, Anthony Bavry and Deepak Bhatt assess current evidence from randomised trials, and propose guidelines for the appropriate use of drug-eluting stents in clinical practice. Deepak Bhatt discusses the history of stents and assesses our current knowledge and considers treatment options for cardiologists and patients in this week's podcast.Continue this conversation on social!Follow us today at...2008-06-2017 min